Overview
Compounds in this area appear in the tissue-repair and recovery literature, often studied for angiogenesis, cytoprotection, and cell-migration signaling. The evidence base is predominantly preclinical, so this guide labels the study type for every cited claim and never reads animal or in-vitro data as human efficacy.
A synthetic pentadecapeptide derived from a gastric protein, one of the most-studied compounds in preclinical tissue-repair research.
Evidence at a glance: Preclinical (animal) evidence
The cited evidence here is preclinical animal-model work, with limited or no human-trial data. Read the research profile accordingly.
Molecular identity
- Molecular formula
- C62H98N16O22
- Molecular weight
- 1419.5 g/mol
- CAS number
- 137525-51-0
- Amino acids
- 15
- Appearance
- White lyophilized powder
- Purity (HPLC)
- 99.3%
Researched mechanism
Studied for pro-angiogenic and cytoprotective signaling (VEGFR2/eNOS pathways) in a wide range of tissue models.
Described as a mechanism characterized in the literature, not an effect you should expect from use.
What the published research shows
Accelerated tendon-to-bone and soft-tissue healing in rodent models.
Gastrointestinal protective effects widely characterized preclinically.
Honest note on evidence: The literature is almost entirely preclinical (animal/in vitro). Human trial data is limited.
Every citation states its study type and population, so preclinical data is never presented as human-efficacy evidence.
How it compares
| Versus | Attribute | Note |
|---|---|---|
| TB-500 | Mechanism | Often co-studied for recovery; TB-500 acts via actin/Tβ4 pathways. |
| KPV | Focus | KPV is studied more for anti-inflammatory signaling. |
Reconstitution
Concentration math only: adding bacteriostatic water to the vial gives the resulting mg/mL shown below. This is not usage guidance.
| Vial | Bacteriostatic water | Concentration |
|---|---|---|
| 5 mg | 2 mL | 2.5 mg/mL |
| 10 mg | 2 mL | 5 mg/mL |
Storage & stability
| State | Temperature | Duration |
|---|---|---|
| Lyophilized (unopened) | -20°C | 24 months |
| Reconstituted | 2–8°C | up to 4 weeks |
Common questions
Is BPC-157 well studied in humans?+
No. The published literature is overwhelmingly preclinical. We state that in the evidence section rather than imply human efficacy.
What is it commonly paired with in research?+
TB-500 in recovery-research protocols; see the related stacks.
